MaBiCo

NOVEMBER 15, 2023

The Future of the Medical Sales Profession: Challenges and Approaches in a Fast-Changing Healthcare Market. Medical sales representatives are professionals who promote medical and health related products or services to healthcare providers, such as hospitals, clinics, pharmacies, and doctors.

Medical sales 52

Medical sales Medical sales reps Sales Medical 52

MedCepts

NOVEMBER 7, 2017

Doctors are natural skeptics. Remember, doctors were educated in scientific communities. Any doctor prescribing them to their patient knows that they could be placing their license at risk. In addition, it needs to be approved either by the FDA or other respective authorizing body. Know Your Competition.

Physicians 52

Physicians Medical sales reps Doctors Medical sales 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.

Government 59

Government Specialization Physicians Education 59

Evolve Your Success

APRIL 11, 2023

There’s less patient pain and ultimately less cost for the healthcare facility. We have launched into the US marketplace and got the product design through FDA. We had some great responses because it solves some problems on the clinician side, the patient side and the healthcare provider side. Cut out the BS.

Sales 52

Sales Medical Medical sales Media 52

Cadensee

JULY 20, 2021

52:21 Uri's opinion about the main problem that needs to be solved for the healthcare market with technology. It's become the main thing that the doctors are looking at now. And I think also you what you see is doctors that grew on this kind of, bedrock, are more open for this because this is now part of the culture.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97